
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1093 | 978 | 1093 | 1082 | 1557 | 2232 |
Fund Return | 9.32% | -2.24% | 9.32% | 2.65% | 9.26% | 8.36% |
Place in category | 95 | 117 | 95 | 304 | 50 | 58 |
% in Category | 12 | 18 | 12 | 56 | 8 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Equity Class A EUR Accumul | 387.93M | 8.01 | 9.46 | 7.36 | ||
European Equity Class C EUR Accumul | 387.93M | 7.93 | 8.97 | 6.88 | ||
European Equity Class Institutional | 387.93M | 8.14 | 10.28 | 8.18 | ||
European Equity Class EUR Accumulat | 387.93M | 9.38 | 2.75 | 8.40 | ||
European Equity Class EUR Income | 387.93M | 9.38 | 2.75 | 8.40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BD0NCR01 | 2.67B | 7.35 | 7.68 | - | ||
Continental European Equity ClassEA | 175.86M | 5.52 | 7.79 | 8.54 | ||
Continental European Equity Class C | 175.86M | 8.52 | 9.79 | 6.86 | ||
Continental European Equity Class Z | 175.86M | 8.75 | 11.22 | 8.24 | ||
Russell Investments Continental EuA | 100.54M | 6.23 | 6.59 | 7.31 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.44 | 474.1 | -1.37% | |
Germany (Federal Republic Of) | DE000BU0E097 | 4.44 | - | - | |
Inditex | ES0148396007 | 4.11 | 46.230 | -0.73% | |
Caixabank | ES0140609019 | 3.89 | 7.26 | -1.22% | |
UniCredit | IT0005239360 | 3.88 | 53.200 | -2.47% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review